Immunoprin

Azathioprine, the active ingredient in Immunoprin, is an antimetabolite presented as an oral formulation for oral use. It suppresses immune activity and is employed in organ transplantation, rheumatoid arthritis and inflammatory bowel disease to help control abnormal immune responses.

GNH USA supplies Immunoprin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Azathioprine is used to modulate immune activity in several chronic conditions: - Organ transplantation: helps prevent graft rejection by inhibiting lymphocyte proliferation. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Inflammatory bowel disease: maintains remission in Crohn's disease and ulcerative colitis by dampening immune‑mediated gut inflammation.

Azathioprine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Fatigue: general feeling of tiredness. - Leukopenia: reduced white‑blood‑cell count. - Hepatotoxicity: elevated liver enzymes. - Rash: skin irritation or itching.

Serious or Rare Side Effects: - Myelosuppression: severe bone‑marrow suppression leading to anemia or infections. - Pancreatitis: inflammation of the pancreas causing abdominal pain. - Severe hepatic injury: jaundice or liver failure. - Opportunistic infections: due to weakened immunity. - Malignancy risk: increased long‑term risk of certain cancers.

Before initiating therapy, several safety considerations are recommended: - Baseline labs: obtain complete blood count and liver function tests. - Monitoring: schedule regular blood work to detect cytopenias or hepatic changes. - Infection risk: advise patients to report fever or signs of infection promptly. - Vaccination: avoid live vaccines while on treatment. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Azathioprine interacts with several drug classes that can alter its efficacy or safety.

Major Interactions (Avoid): - Allopurinol: may cause severe bone‑marrow suppression. - Warfarin: increased anticoagulant effect leading to bleeding. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - Ribavirin: additive hematologic toxicity. - ACE inhibitors: potential for increased renal impairment. - NSAIDs: may exacerbate gastrointestinal irritation.